C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/14/2006	US20060281146 Novel compositions and methods for the treatment of immune related diseases
12/14/2006	US20060281145 Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
12/14/2006	US20060281139 Carrier and method for the detection of anti-borrelia antibodies and test kit for use in the diagnosis of Lyme borreliosis infections
12/14/2006	US20060281133 Targeted fusion proteins and methods for the characterization of cellular membrane domains
12/14/2006	US20060281127 Promoter sequences for urocortin II and the use thereof
12/14/2006	US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006	US20060281117 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-1G subunit (CACNA1G)
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060281090 Capsid-modified adenovirus vectors and methods of using the same
12/14/2006	US20060281089 Detecting presence of mutant bcl gene of given sequence; identifying patients resistant to chemotherapy or radiation treatments
12/14/2006	US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006	US20060281078 Human fast-1 gene
12/14/2006	US20060281073 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system
12/14/2006	US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy
12/14/2006	US20060281070 Synthetic genetic expression cassette comprising human preproenkephalin sequences for use in treating neuropathic pain
12/14/2006	US20060280804 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
12/14/2006	US20060280780 Antimicrobial polypeptides
12/14/2006	US20060280758 Modified vaccinia ankara virus variant
12/14/2006	US20060280757 Flavivirus vaccine delivery system
12/14/2006	US20060280752 Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseases
12/14/2006	US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	US20060280747 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
12/14/2006	US20060280742 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis
12/14/2006	US20060280739 Novel human beta-2 integrin alpha subunit
12/14/2006	US20060280737 Reducing body weight or food intake ; binding to antibody
12/14/2006	US20060280736 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/14/2006	US20060280735 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/14/2006	US20060280731 Novel substrate for Rpn11 enzymatic activity
12/14/2006	US20060280728 Trimeric OX40-immunoglobulin fusion protein and methods of use
12/14/2006	US20060280699 Effect of porcine sheath proteins on the regeneration activity of periodontal ligament
12/14/2006	US20060280688 noninvasive imaging in near-infrared (NIR) spectral range for tumor detection with a ligand-conjugated fluorescent probe
12/14/2006	US20060280684 Using lymphocyte gene expression profiles as diagnostic indicator of asthma, allergic and autoimmune disorders
12/14/2006	US20060280683 Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity
12/14/2006	CA2611539A1 Insect-specific protease recognition sequences
12/14/2006	CA2611416A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method for the production thereof
12/14/2006	CA2611234A1 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof
12/14/2006	CA2611200A1 Stabilised il-21 compositions
12/14/2006	CA2611002A1 Stimulation of pancreatic .beta. cell proliferation
12/14/2006	CA2610976A1 Use of stefin a as a scaffold protein
12/14/2006	CA2609865A1 Modulation of cholesteryl ester transfer protein (cetp) activity
12/14/2006	CA2608192A1 Incorporation of non-naturally encoded amino acids into proteins
12/14/2006	CA2607841A1 Polypeptides having antimicrobial activity and polynucleotides encoding same
12/14/2006	CA2586909A1 Auristatins having an aminobenzoic acid unit at the n terminus
12/13/2006	EP1731912A2 Peptide selection method
12/13/2006	EP1731619A2 Tumour markers
12/13/2006	EP1731614A1 Reversible nuclear genetic system for male sterility in transgenic plants
12/13/2006	EP1731612A1 Recombinant herpesvirus and utilization of the same
12/13/2006	EP1731611A2 Eimeria hydrophilic polypeptides as vaccines
12/13/2006	EP1731610A1 Proteins imparting boron-tolerance and genes thereof
12/13/2006	EP1731608A1 Marker gene for arthrorheumatism test
12/13/2006	EP1731605A1 Cancer antigen peptides derived from wt1
12/13/2006	EP1731602A1 Pharmaceutical composition for lowering blood sugar level
12/13/2006	EP1731601A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE II alpha KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
12/13/2006	EP1731597A1 Selenium-enriched liquid media for the cultivation of siliceous sponges and for biogenic silica production
12/13/2006	EP1731531A2 Multiple cytokine-antibody complexes
12/13/2006	EP1731529A1 Calcium ion leakage inhibitors
12/13/2006	EP1731528A1 Process for producing solubilized keratin
12/13/2006	EP1731174A2 Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond
12/13/2006	EP1731171A1 Preventive/remedy for respiratory diseases
12/13/2006	EP1731167A1 Vaccine against hbv and hpv
12/13/2006	EP1731166A2 Streptococcus pneumoniae proteins and vaccines
12/13/2006	EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/13/2006	EP1731163A2 Treatment of allergic conditions by use of IL 21
12/13/2006	EP1731161A1 Compositions for the treatment of diseases associated with elevated sphingolipid concentrations
12/13/2006	EP1731144A1 Identification of genes altered in multiple myeloma
12/13/2006	EP1730520A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
12/13/2006	EP1730499A2 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters
12/13/2006	EP1730297A1 Method for screening agents modulating a lkb alpha protein ubiquitination and means for carrying out said method
12/13/2006	EP1730291A2 Nitrile hydratase of rhodococcus
12/13/2006	EP1730282A1 Glycosylation variants of ricin-like proteins
12/13/2006	EP1730278A1 Method for preparation and purification of recombinant proteins
12/13/2006	EP1730195A2 Estrogen receptors and methods of use
12/13/2006	EP1730189A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
12/13/2006	EP1730188A2 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity
12/13/2006	EP1730187A1 Immunosuppressive cytokine
12/13/2006	EP1730186A2 Bmp-7 variants with improved properties
12/13/2006	EP1730185A1 Cancer associated antigens
12/13/2006	EP1730184A2 Improved interleukin-2 muteins
12/13/2006	EP1730183A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
12/13/2006	EP1730182A2 Chimeric vegf peptides
12/13/2006	EP1730181A2 Novel brain natriuretic peptide variants and methods of use thereof
12/13/2006	EP1730180A1 Antifungal peptides
12/13/2006	EP1730179A1 Novel mannose-specific adhesins and their use
12/13/2006	EP1730178A2 Novel antibiotic alternatives
12/13/2006	EP1730177A2 Cyanide tolerant nitrilhydratases
12/13/2006	EP1730176A2 Mvl, an antiviral protein from a cyanobacterium
12/13/2006	EP1730175A1 Optimized expression of hpv 52 l1 in yeast
12/13/2006	EP1730174A1 Peptide carrier for drug delivery
12/13/2006	EP1730173A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
12/13/2006	EP1730172A1 Methods and compositions for the treatment of gastrointestinal disorders
12/13/2006	EP1730170A2 Method for inhibiting immune complex formation in a subjetc
12/13/2006	EP1730169A2 Metal-containing nanolayered composites, and applications thereof
12/13/2006	EP1730168A2 Functional method for generating or screening for ligands which modulate steroid hormone receptors
12/13/2006	EP1729832A2 Composite materials
12/13/2006	EP1729821A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
12/13/2006	EP1729810A2 Methods of reducing aggregation of il-1ra
12/13/2006	EP1729803A2 Therapeutic use of anti-cs1 antibodies
12/13/2006	EP1729801A2 Mutant viral nucleic acids and vaccine containing same
12/13/2006	EP1729795A2 Albumin fusion proteins

1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 2916